semaglutide side effects oral Semaglutide: Double-edged Sword with Risks and Benefits Treatment algorithm for oral semaglutide

However, the differences in weight loss did not translate to significant changes in the risk of obesity-related cancers or, for lung cancer, a non-obesity-related tumor

Addiction researchers see a need for new medications The new findings are striking, said Dr

Tirzepatide, a dual GIP/GLP-1 receptor agonist approved for diabetes management and weight loss, works through distinct mechanisms from testosterone replacement therapy (TRT), which restores physiological hormone levels in men with confirmed low testosterone

The purpose of the microdose phase is adaptation, not results

doi: 10.1038/s41467-026-72861-3 This article is a rework of a press release issued by the University of California, San Diego